Stereoscopic digital mammography, a new 3D technique, significantly improves the accuracy of breast cancer detection in high-risk women.
Stereoscopic digital mammography, a new three-dimensional technique, significantly improves the accuracy of breast cancer detection in high-risk women, according to a study published online in the journal Radiology.
Using stereoscopic digital mammography (SDM), physicians can see beyond the two-dimensional images provided by X-ray mammography, in which surrounding normal tissue can mask lesions. Modified digital mammography equipment allows the X-ray tube to move separately from the cassette and resulting images are viewed on two monitors. This provides slightly different views of the internal structure of the breast.
Researchers from Atlanta compared SDM images with 2-D digital mammograms from 779 women who were at high risk of developing breast cancer. A total of 1,298 exams were independently interpreted by two radiologists, whose findings were correlated with one-year follow-up findings or biopsy.
The findings showed that the specificity of SDM was 91.2 percent, better than the 87.8 percent rate for 2-D digital mammography. The accuracy was 90.0 percent for SDM, compared with 87.4 percent for 2-D imaging.
“We found that the stereoscopic technique could significantly decrease the need for calling back women for additional exams,” said Carl. J. D’Orsi, MD, from the Department of Radiology and Imaging Sciences at Emory University School of Medicine and the Winship Cancer Institute at Emory.
Further study is needed as the radiation dose used for this study was double the standard dose, researchers said.
“Now that we now the technique is worthwhile,” D’Orsi said, “we’re repeating the study in the general population with a dose comparable to routine screening mammography.”
Considering Breast- and Lesion-Level Assessments with Mammography AI: What New Research Reveals
June 27th 2025While there was a decline of AUC for mammography AI software from breast-level assessments to lesion-level evaluation, the authors of a new study, involving 1,200 women, found that AI offered over a seven percent higher AUC for lesion-level interpretation in comparison to unassisted expert readers.
Contrast-Enhanced Mammography and High-Concentration ICM Dosing: What a New Study Reveals
June 16th 2025New research showed a 96 to 97 percent sensitivity for contrast-enhanced mammography (CEM) with an increased iodine delivery rate facilitating robust contrast enhancement for women with aggressive breast cancer.
Mammography AI Platform for Five-Year Breast Cancer Risk Prediction Gets FDA De Novo Authorization
June 2nd 2025Through AI recognition of subtle patterns in breast tissue on screening mammograms, the Clairity Breast software reportedly provides validated risk scoring for predicting one’s five-year risk of breast cancer.